Amidoheterocycles as modulators of the melanocortin-4 receptor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S210010, C514S252130, C514S422000, C514S423000, C544S359000, C546S139000, C548S517000, C548S518000

Reexamination Certificate

active

07049323

ABSTRACT:
Novel azetidinyl and pyrrolidinyl compounds are ligands of melanocortin-4 receptors and are useful for treating conditions responsive to the modulation of melanocortin-4 receptors such as obesity, diabetes, and sexual dysfunction.

REFERENCES:
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/70337 (2001-09-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/15909 (2002-02-01), None
patent: WO 02/066869 (2002-08-01), None
patent: WO 02/068387 (2002-09-01), None
patent: WO 02/068388 (2002-09-01), None
patent: WO 02/070511 (2002-09-01), None
patent: WO 02/079146 (2002-10-01), None
patent: WO 03/007949 (2003-01-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Amidoheterocycles as modulators of the melanocortin-4 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amidoheterocycles as modulators of the melanocortin-4 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidoheterocycles as modulators of the melanocortin-4 receptor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3580823

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.